CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
---|---|---|---|---|---|---|
C32504 | BRD-K94992087 | BRD-K94992087 | -- | -- | -- | Details |
C32505 | BRD-K94993557 | BRD-K94993557 | -- | -- | -- | Details |
C32506 | BRD-K94993773 | BRD-K94993773 | -- | -- | -- | Details |
C32507 | BRD-K95007304 | BRD-K95007304 | -- | -- | -- | Details |
C32508 | BRD-K95007662 | BRD-K95007662 | -- | -- | -- | Details |
C32509 | BRD-K95010912 | BRD-K95010912 | -- | -- | -- | Details |
C32510 | BRD-K95014129 | BRD-K95014129 | -- | -- | -- | Details |
C32511 | BRD-K95014616 | BRD-K95014616 | -- | -- | -- | Details |
C32512 | BRD-K95015809 | 2-cyanopyrimidine | -- | -- | 2-CYANOPYRIMIDINE | Details |
C32513 | BRD-K95016030 | BRD-K95016030 | -- | -- | -- | Details |
C32514 | BRD-K95017486 | BRD-K95017486 | -- | -- | -- | Details |
C32515 | BRD-K95018971 | BRD-K95018971 | -- | -- | -- | Details |
C32516 | BRD-K95021846 | BRD-K95021846 | -- | -- | -- | Details |
C32517 | BRD-K95023134 | BRD-K95023134 | -- | -- | -- | Details |
C32518 | BRD-K95033227 | BRD-K95033227 | -- | -- | -- | Details |
C32519 | BRD-K95033255 | BRD-K95033255 | -- | -- | -- | Details |
C32520 | BRD-K95035301 | BRD-K95035301 | -- | -- | -- | Details |
C32521 | BRD-K95037415 | BRD-K95037415 | -- | -- | -- | Details |
C32522 | BRD-K95041551 | BRD-K95041551 | -- | -- | -- | Details |
C32523 | BRD-K95042038 | BRD-K95042038 | -- | -- | -- | Details |
C32524 | BRD-K95044179 | BRD-K95044179 | -- | -- | -- | Details |
C32525 | BRD-K95047050 | BRD-K95047050 | -- | -- | -- | Details |
C32526 | BRD-K95047072 | BRD-K95047072 | -- | -- | -- | Details |
C32527 | BRD-K95048194 | BRD-K95048194 | -- | -- | -- | Details |
C32528 | BRD-K95048846 | VU-0413255-1 | -- | -- | -- | Details |
C32529 | BRD-K95052025 | BRD-K95052025 | -- | -- | -- | Details |
C32530 | BRD-K95057125 | BRD-K95057125 | -- | -- | -- | Details |
C32531 | BRD-K95062171 | BRD-K95062171 | -- | -- | -- | Details |
C32532 | BRD-K95063618 | BRD-K95063618 | -- | -- | -- | Details |
C32533 | BRD-K95068765 | BRD-K95068765 | -- | -- | -- | Details |
C32534 | BRD-K95074209 | BRD-K95074209 | -- | -- | -- | Details |
C32535 | BRD-K95080525 | BRD-K95080525 | -- | -- | -- | Details |
C32536 | BRD-K95080859 | BRD-K95080859 | -- | -- | -- | Details |
C32537 | BRD-K95090559 | BRD-K95090559 | -- | -- | -- | Details |
C32538 | BRD-K95091188 | BRD-K95091188 | -- | -- | -- | Details |
C32539 | BRD-K95096346 | BRD-K95096346 | -- | -- | -- | Details |
C32540 | BRD-K95105171 | BRD-K95105171 | -- | -- | -- | Details |
C32541 | BRD-K95110148 | beta-funaltrexamine | OPRM1 | Opioid receptor antagonist | -- | Details |
C32542 | BRD-K95111937 | BRD-K95111937 | -- | -- | -- | Details |
C32543 | BRD-K95114614 | BRD-K95114614 | -- | -- | -- | Details |
C32544 | BRD-K95117060 | BRD-K95117060 | -- | -- | -- | Details |
C32545 | BRD-K95118263 | BRD-K95118263 | -- | -- | -- | Details |
C32546 | BRD-K95121261 | BRD-K95121261 | -- | -- | -- | Details |
C32547 | BRD-K95125640 | BRD-K95125640 | -- | -- | -- | Details |
C32548 | BRD-K95129711 | BRD-K95129711 | -- | -- | -- | Details |
C32549 | BRD-K95133676 | BRD-K95133676 | -- | -- | -- | Details |
C32550 | BRD-K95138368 | BRD-K95138368 | -- | -- | -- | Details |
C32551 | BRD-K95138506 | BRD-K95138506 | -- | -- | -- | Details |
C32552 | BRD-K95142134 | BRD-K95142134 | -- | -- | -- | Details |
C32553 | BRD-K95142244 | talazoparib | PARP2; PARP1 | PARP inhibitor | -- | Details |
C32554 | BRD-K95146554 | BRD-K95146554 | -- | -- | -- | Details |
C32555 | BRD-K95147502 | BRD-K95147502 | -- | -- | -- | Details |
C32556 | BRD-K95147720 | BRD-K95147720 | -- | -- | -- | Details |
C32557 | BRD-K95148987 | BRD-K95148987 | -- | -- | -- | Details |
C32558 | BRD-K95149906 | BRD-K95149906 | -- | -- | -- | Details |
C32559 | BRD-K95152807 | BRD-K95152807 | -- | -- | -- | Details |
C32560 | BRD-K95153342 | BRD-K95153342 | -- | -- | -- | Details |
C32561 | BRD-K95153427 | BRD-K95153427 | -- | -- | -- | Details |
C32562 | BRD-K95154332 | BRD-K95154332 | -- | -- | -- | Details |
C32563 | BRD-K95160020 | BRD-K95160020 | -- | -- | -- | Details |
C32564 | BRD-K95168667 | BRD-K95168667 | -- | -- | -- | Details |
C32565 | BRD-K95171874 | BRD-K95171874 | -- | -- | -- | Details |
C32566 | BRD-K95190454 | BRD-K95190454 | -- | -- | -- | Details |
C32567 | BRD-K95192796 | BRD-K95192796 | -- | -- | -- | Details |
C32568 | BRD-K95193599 | BRD-K95193599 | -- | -- | -- | Details |
C32569 | BRD-K95195947 | BRD-K95195947 | -- | -- | -- | Details |
C32570 | BRD-K95196255 | BRD-K95196255 | -- | -- | -- | Details |
C32571 | BRD-K95196306 | BRD-K95196306 | -- | -- | -- | Details |
C32572 | BRD-K95202259 | ML-3163 | MAPK14 | P38 MAPK inhibitor | -- | Details |
C32573 | BRD-K95202918 | BRD-K95202918 | -- | -- | -- | Details |
C32574 | BRD-K95204731 | BRD-K95204731 | -- | -- | -- | Details |
C32575 | BRD-K95208083 | SA-1457472 | -- | -- | -- | Details |
C32576 | BRD-K95212245 | DM-161 | -- | -- | -- | Details |
C32577 | BRD-K95213130 | BRD-K95213130 | -- | -- | -- | Details |
C32578 | BRD-K95218317 | BRD-K95218317 | -- | -- | -- | Details |
C32579 | BRD-K95237249 | probenecid | SLC22A11; SLC22A6; SLC22A8 | Uricosuric blocker | -- | Details |
C32580 | BRD-K95241801 | BRD-K95241801 | -- | -- | -- | Details |
C32581 | BRD-K95244186 | BRD-K95244186 | -- | -- | -- | Details |
C32582 | BRD-K95246884 | BRD-K95246884 | -- | -- | -- | Details |
C32583 | BRD-K95251122 | BRD-K95251122 | -- | -- | -- | Details |
C32584 | BRD-K95253417 | BRD-K95253417 | -- | -- | -- | Details |
C32585 | BRD-K95260951 | asenapine | ADRB2; DRD1; DRD2; HRH1; HTR1A; HTR1B; HTR2A | Dopamine receptor antagonist; Serotonin receptor antagonist | -- | Details |
C32586 | BRD-K95264594 | BRD-K95264594 | -- | -- | -- | Details |
C32587 | BRD-K95265783 | BRD-K95265783 | -- | -- | -- | Details |
C32588 | BRD-K95269843 | BRD-K95269843 | -- | -- | -- | Details |
C32589 | BRD-K95270854 | BRD-K95270854 | -- | -- | -- | Details |
C32590 | BRD-K95273033 | BRD-K95273033 | -- | -- | -- | Details |
C32591 | BRD-K95275773 | BRD-K95275773 | -- | -- | -- | Details |
C32592 | BRD-K95284932 | BRD-K95284932 | -- | -- | -- | Details |
C32593 | BRD-K95285735 | BRD-K95285735 | -- | -- | -- | Details |
C32594 | BRD-K95286134 | BRD-K95286134 | -- | -- | -- | Details |
C32595 | BRD-K95286989 | BRD-K95286989 | -- | -- | -- | Details |
C32596 | BRD-K95292280 | SB-657510 | UTS2R | Urotensin receptor antagonist | -- | Details |
C32597 | BRD-K95294904 | BRD-K95294904 | -- | -- | -- | Details |
C32598 | BRD-K95298605 | SA-247636 | -- | -- | -- | Details |
C32599 | BRD-K95309561 | dienestrol | ESR1 | Estrogen receptor agonist | -- | Details |
C32600 | BRD-K95321016 | BRD-K95321016 | -- | -- | -- | Details |
C32601 | BRD-K95323025 | BRD-K95323025 | -- | -- | -- | Details |
C32602 | BRD-K95323755 | BRD-K95323755 | -- | -- | -- | Details |
C32603 | BRD-K95323941 | BRD-K95323941 | -- | -- | -- | Details |